ferric ferricyanide has been researched along with metoprolol in 1 studies
Studies (ferric ferricyanide) | Trials (ferric ferricyanide) | Recent Studies (post-2010) (ferric ferricyanide) | Studies (metoprolol) | Trials (metoprolol) | Recent Studies (post-2010) (metoprolol) |
---|---|---|---|---|---|
19 | 0 | 4 | 5,821 | 1,743 | 1,304 |
Protein | Taxonomy | ferric ferricyanide (IC50) | metoprolol (IC50) |
---|---|---|---|
Beta-2 adrenergic receptor | Homo sapiens (human) | 2.573 | |
Beta-1 adrenergic receptor | Homo sapiens (human) | 0.176 | |
Cytochrome P450 2C9 | Homo sapiens (human) | 4.87 | |
Cytochrome P450 2J2 | Homo sapiens (human) | 4.87 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hallak, H; Muglia, P; Pastino, G; Rabinovich-Guilatt, L; Spiegelstein, O; Steiner, L | 1 |
1 other study(ies) available for ferric ferricyanide and metoprolol
Article | Year |
---|---|
Metoprolol-pridopidine drug-drug interaction and food effect assessments of pridopidine, a new drug for treatment of Huntington's disease.
Topics: Area Under Curve; Cells, Cultured; Cross-Over Studies; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP2D6 Inhibitors; Dextromethorphan; Drug Interactions; Female; Ferricyanides; Food-Drug Interactions; Healthy Volunteers; Hepatocytes; Humans; Huntington Disease; Male; Metoprolol; Microsomes, Liver; Middle Aged; Piperidines | 2017 |